Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bromfenac Ophthalmic Solution for ocular inflammation and pain in cataract surgery
NCT01367249Phase 3Completed
- Sponsor
- Bausch + Lomb
- Start
- May 2011
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bromfenac sodium in ocular inflammation, sponsored by Bausch + Lomb. Started May 2011; status: completed.
02
Drugs
bromfenac sodium
03
Conditions
ocular inflammation
Beyond the preview
Go deeper on NCT01367249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01367249.